SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeltic Regulatory News (CCP)

Share Price Information for Celtic (CCP)

Share Price is delayed by 15 minutes
Get Live Data
248.00    0.00 (0.00%)
Bid:
246.00
Ask:
250.00
Spread: 4.00 (1.626%)
Market Cap: £235.82m
CCP Live PriceLast checked at - London Stock Exchange

Intraday Celtic Share Chart

Schedule 1 - Celtic plc

19 Dec 2005 07:00

AIM19 December 2005 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME:.Celtic plc COMPANY ADDRESS:Celtic Park, Glasgow COMPANY POSTCODE:G40 3RE COUNTRY OF INCORPORATION:Scotland reg no: SC003487 COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITSINVESTMENT STRATEGY TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (J)OF THE AIM RULES:The Group comprises five divisions as follows:, professional football division,multimedia and communications division, merchandising division, stadiumenterprises division and youth development division DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares,nominal value and issue price to which it seeks admission and the number andtype to be held as treasury shares):Up to 81,014,689 Ordinary Shares16,800,943 Preference Shares18,012,448 CPO shares CAPITAL TO BE RAISED ON ADMISSION:Up to £15 million FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Brian Quinn CBE - non executive chairmanThomas Eardley Allison - non executiveDermot Fachtna Desmond - non executiveEric Hagman CBE - non executivePeter Thomas Lawwell - chief executiveBrian James McBride - non executiveEric James Riley - finance directorBrian David Henderson Wilson - non executive PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS APERCENTAGE OF THE ISSUED SHARE CAPITAL BEFORE AND AFTER ADMISSION:Before Dermot Desmond - 20.23% of the Ordinary SharesDermot Desmond - 44.4% of the CPO SharesDermot Desmond - 30.54% of the Preference Shares John S Keane - 5.83% of the Ordinary SharesJohn S Keane - 3.94% of the Preference SharesChristopher D Trainer - 3.01% of Ordinary SharesChristopher D Trainer - 4.29% of Preference Shares The Bank of New York (Nominees) Limited - 3.04% of Ordinary Shares N Y Nominees Limited - 8.88% of CPO SharesMartin O' Neill - 8.88% of CPO SharesAurum Nominees Limited - 4.44% of CPO SharesNatwest FIS Nominees Limited - 4.44% of CPO SharesPrincella Investments Limited - 4.44% of CPO Shares Securities Services Nominees Limited 3.04% of Preference Shares NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE2, PARAGRAPH (H) OF THE AIM RULES:n/a ANTICIPATED ACCOUNTING REFERENCE DATE:30 June EXPECTED ADMISSION DATE:22 December NAME AND ADDRESS OF NOMINATED ADVISER:SEYMOUR PIERCE LIMITED, BUCKLERSBURY HOUSE, 3 QUEEN VICTORIA STREET, LONDON EC4N 8EL NAME AND ADDRESS OF BROKER:SEYMOUR PIERCE LIMITED, BUCKLERSBURY HOUSE, 3 QUEEN VICTORIA STREET, LONDON EC4N 8EL DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BEAVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THEAPPLICANT AND THE ADMISSION OF ITS SECURITIES: Copies of the admission document which will contain full details of Celtic plc.and the admission of its securities will be available to the public, free ofcharge, from the offices of Seymour Pierce Limited, Bucklersbury House, 3 QueenVictoria Street, London EC4N 8EL from publication and thereafter for one monthfollowing admission. DATE OF NOTIFICATION:16 December 2005 NEW/UPDATENEW This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Jun 202612:00 pmRNSMartin O’Neill appointed as permanent Manager
15th Apr 20264:30 pmRNSDirector Retirement
13th Feb 20265:30 pmRNSInterim Report - 31 December 2025
19th Jan 202612:51 pmRNSIssued share capital
6th Jan 20267:00 amRNSInterim Manager Appointment
5th Jan 20263:00 pmRNSWilfried Nancy leaves Celtic
17th Dec 20253:40 pmRNSDirectorate change
5th Dec 202510:45 amRNSIssued share capital
4th Dec 20257:00 amRNSAppointment of Wilfred Nancy
25th Nov 20256:29 pmRNSResult of AGM
21st Nov 20255:45 pmRNSAGM 2025
20th Nov 20254:05 pmRNSHolding(s) in Company
28th Oct 20254:25 pmRNSNotice of AGM
28th Oct 20257:00 amRNSBrendan Rodgers to leave Celtic
14th Oct 20252:05 pmRNSHolding(s) in Company
19th Sep 20256:30 pmRNSResults for the year ended 30 June 2025
29th Aug 20257:00 amRNSIssue of Equity
1st Aug 202511:00 amRNSScrip Dividend Price
17th Jul 20252:02 pmRNSDividend Timetable
14th Jul 20254:46 pmRNSIssued Share Capital
19th Feb 20252:04 pmRNSIssued share capital
14th Feb 20258:20 amRNSIssued share capital
10th Feb 20255:35 pmRNSInterim Report - 31 December 2024
25th Nov 20247:00 amRNSAGM Outcome of voting
20th Nov 20245:23 pmRNSIssued share capital
22nd Oct 20243:37 pmRNSNotice of AGM
16th Sep 20245:30 pmRNSResults for the year ended 30 June 2024
30th Aug 20247:00 amRNSIssue of Equity
28th Aug 20247:00 amRNSIssued share capital
20th Aug 20245:08 pmRNSIssued share capital
6th Aug 20245:47 pmRNSTrading Update
1st Aug 20244:58 pmRNSScrip Dividend Price
18th Jul 20245:24 pmRNSDividend Timetable
10th Jul 20242:04 pmRNSIssued share capital
4th Jul 20243:47 pmRNSIssued share capital
27th Jun 202412:45 pmRNSIssued share capital
13th Jun 20248:55 amRNSIssued Share Capital
23rd May 20243:27 pmRNSIssued share capital
19th Mar 20247:00 amRNSIssued share capital
23rd Feb 20243:00 pmRNSInterim Report - 31 December 2023
11th Jan 20243:21 pmRNSIssued share capital
19th Dec 20233:29 pmRNSIssued share capital
22nd Nov 20234:00 pmRNSResult of AGM
24th Oct 20234:05 pmRNSNotice of AGM & posting of Annual Report
2nd Oct 202310:15 amRNSIssued share capital
18th Sep 20235:30 pmRNSResults for the year ended 30 June 2023
31st Aug 20237:00 amRNSIssue of Equity
7th Aug 20233:45 pmRNSScrip Dividend Price
2nd Aug 20237:00 amRNSIssue of Equity
20th Jul 20236:10 pmRNSDividend Timetable

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.